Form 4 Filing for Alpha Tau Medical Ltd. - Officer/Director Transaction

This filing details transactions made by Raphi Levy, the Chief Financial Officer of Alpha Tau Medical Ltd. On July 1, 2026, Mr. Levy acquired 2,127 ordinary shares at a price of $2.98 per share, increasing his post-transaction holdings to 92,307 shares. Subsequently, on the same day, he disposed of 2,127 ordinary shares at a price of $13.0189 per share, resulting in a post-transaction shareholding of 90,180 shares. The transactions were reported on Form 4, with the signature date of July 2, 2026.